Key result
miR-122 binding stimulates HCV translation by suppressing secondary structures that interfere with IRES function.
Why the study?
The mechanism by which microRNA-122 stimulates the HCV internal ribosome entry site to promote viral replication was not fully understood.
miR-122 amplifies hepatitis C virus translation by acting as an RNA chaperone to suppress alternative secondary structures and promote functional IRES folding.
Does not support miR-122 modulation in HCV patients; leaves open therapeutic translation from animal models.
The liver-specific microRNA-122 (miR-122) recognizes two conserved sites at the 5' end of the hepatitis C virus (HCV) genome and contributes to stability, translation, and replication of the viral RNA. We show that stimulation of the HCV internal ribosome entry site (IRES) by miR-122 is essential for efficient viral replication. The mechanism relies on a dual function of the 5' terminal sequence in the complementary positive (translation) and negative strand (replication), requiring different secondary structures. Predictions and experimental evidence argue for several alternative folds involving the miR-binding region (MBR) adjacent to the IRES and interfering with its function. Mutations in the MBR, designed to suppress these dysfunctional structures indeed stimulate translation independently of miR-122. Conversely, MBR mutants favoring alternative folds show impaired IRES activity. Our results therefore suggest that miR-122 binding assists the folding of a functional IRES in an RNA chaperone-like manner by suppressing energetically favorable alternative secondary structures.
No takes yet. Share an insight, caveat, or question.
Schult et al. (2018) studied Hepatitis C Virus (HCV) infection (in vitro model). miR-122 binding and 5' UTR mutations vs. miR-122 mutant / wild type HCV 5' UTR was evaluated on HCV translation and replication efficiency. Binding of miR-122 to the hepatitis C virus genome stimulates translation by suppressing energetically favorable alternative secondary structures that interfere with internal ribosomal entry site function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: